デフォルト表紙
市場調査レポート
商品コード
1547259

大腸菌検査の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global E. Coli Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032


出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
大腸菌検査の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

大腸菌検査市場の世界需要は、2023年の22億636万米ドルから2032年には44億317万米ドル近くの市場規模に達すると推定され、調査期間2024~2032年のCAGRは7.98%です。

大腸菌検査は、胃腸感染症、尿路感染症、食中毒など、さまざまな感染症や疾患の原因となる大腸菌の検出と分析を行う。検査方法には通常、培養ベースの技術、PCR(ポリメラーゼ連鎖反応)などの分子診断法、免疫測定法などがあります。正確でタイムリーな検査は、感染症の診断、食品の安全性の確保、環境汚染のモニタリングにとって極めて重要です。検査技術の進歩は、感度、特異性、納期を改善し、より効果的な疾病管理と予防戦略に貢献することを目指しています。

市場力学

大腸菌に関連する感染症や食中毒の増加により、効果的な大腸菌検査ソリューションに対する需要が高まっています。迅速診断検査や分子アッセイなどの検査技術の進歩により、大腸菌検出の精度とスピードが向上しています。食品の安全性に対する意識の高まりや厳しい規制の実施も、食品や水源の定期的な検査を必要とするため、市場の成長を後押ししています。公衆衛生と環境モニタリングへの注目の高まりも、革新的な大腸菌検査ソリューションの機会を生み出しています。医療インフラの拡大と診断研究への投資の増加は、市場開発をさらに後押しします。診断薬メーカーと研究機関の共同研究は、新しく改良された検査法の開発を促進しています。しかし、高コストと規制上の課題が大腸菌検査市場の成長を阻害する可能性があります。

本調査レポートでは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは大腸菌検査の世界市場における各セグメントを包括的に評価することもできます。大腸菌検査業界の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

大腸菌検査市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供することで、戦略担当者がそれぞれの製品やサービスの対象層を特定し、今後のビジネス機会に役立てることができます。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける大腸菌検査市場の現在と将来の需要を強調する地域展望を取り上げます。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 大腸菌検査-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 世界の大腸菌検査市場分析:検査法別

  • 検査法別概要
  • 検査法別過去・予測データ分析
  • 臨床検査法(酵素免疫測定法(EIA)、ポリメラーゼ連鎖反応(PCR)検査、その他)
  • 環境検査法(酵素基質法、膜濾過法(MF)、多重管発酵法(MTF))

第6章 大腸菌検査の世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 臨床検査法(診断ラボ、病院、医院)
  • 環境検査法(ボトル水供給業者、家庭・飲料水供給業者、廃水処理機関、その他(政府機関など))

第7章 世界の大腸菌検査市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第8章 大腸菌検査企業の競合情勢

  • 大腸菌検査市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • IDEXX Laboratories Inc.
  • Meridian Bioscience Inc.
  • Becton, Dickinson And Company
  • Nanologix Inc.
  • Thermo Fisher Scientific Inc.
  • CPI International Inc.
  • Bio-Rad Laboratories Inc.
  • Pro-Lab Diagnostics Inc.
  • Alere Inc.
  • BioMerieux Inc.
  • Other
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Testing Methods (USD MN)
  • Clinical Testing Methods (Enzyme Immunoassays (EIA), Polymerase Chain Reaction, (PCR) Tests, Others) Market Sales By Geography (USD MN)
  • Environmental Testing (Enzyme Substrate Methods, Membrane Filtration (MF), Multiple Tube Fermentation (MTF) Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Clinical Testing Methods (Diagnostic Laboratories, Hospital, Physician Offices) Market Sales By Geography (USD MN)
  • Environmental Testing (Bottled Water Suppliers, Home and Drinking Water Suppliers, Waste Water Treatment Organizations, Others (Government Agencies, etc.) Market Sales By Geography (USD MN)
  • Global E. Coli Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of E. Coli Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global E. Coli Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Testing Methods
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Testing Methods (USD MN)
  • Clinical Testing Methods (Enzyme Immunoassays (EIA), Polymerase Chain Reaction, (PCR) Tests, Others) Market Sales By Geography (USD MN)
  • Environmental Testing (Enzyme Substrate Methods, Membrane Filtration (MF), Multiple Tube Fermentation (MTF) Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Clinical Testing Methods (Diagnostic Laboratories, Hospital, Physician Offices) Market Sales By Geography (USD MN)
  • Environmental Testing (Bottled Water Suppliers, Home and Drinking Water Suppliers, Waste Water Treatment Organizations, Others (Government Agencies, etc.) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115420

The global demand for E. Coli Testing Market is presumed to reach the market size of nearly USD 4403.17 Million by 2032 from USD 2206.36 Million in 2023 with a CAGR of 7.98% under the study period 2024-2032.

E. coli testing involves detecting and analyzing Escherichia coli (E. coli) bacteria, which can cause a range of infections and diseases, including gastrointestinal infections, urinary tract infections, and foodborne illnesses. Testing methods typically include culture-based techniques, molecular diagnostics such as PCR (polymerase chain reaction), and immunoassays. Accurate and timely testing is crucial for diagnosing infections, ensuring food safety, and monitoring environmental contamination. The advancement of testing technologies aims to improve sensitivity, specificity, and turnaround times, contributing to more effective disease management and prevention strategies.

MARKET DYNAMICS

The increasing prevalence of E. coli-related infections and foodborne illnesses creates a strong demand for effective E. coli testing solutions. Advances in testing technologies, such as rapid diagnostic tests and molecular assays, are improving the accuracy and speed of E. coli detection. Growing awareness about food safety and implementing stringent regulations also drive market growth, as they necessitate regular testing of food and water sources. The rising focus on public health and environmental monitoring also creates opportunities for innovative E. coli testing solutions. Expanding healthcare infrastructure and increasing investments in diagnostic research further support market development. Collaborations between diagnostic companies and research institutions are facilitating the development of new and improved testing methods. However, high costs and regulatory challenges may hinder E. coli testing market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of E. Coli Testing. The growth and trends of E. Coli Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the E. Coli Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Testing Methods

  • Clinical Testing Methods (Enzyme Immunoassays (EIA), Polymerase Chain Reaction, (PCR) Tests, Others)
  • Environmental Testing (Enzyme Substrate Methods, Membrane Filtration (MF), Multiple Tube Fermentation (MTF)

By End User

  • Clinical Testing Methods (Diagnostic Laboratories, Hospital, Physician Offices)
  • Environmental Testing (Bottled Water Suppliers, Home and Drinking Water Suppliers, Waste Water Treatment Organizations, Others (Government Agencies, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the E. Coli Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the E. Coli Testing market include IDEXX Laboratories Inc., Meridian Bioscience Inc., Becton, Dickinson And Company, Thermo Fisher Scientific Inc., CPI International Inc., Bio-Rad Laboratories Inc., Pro-Lab Diagnostics Inc., Alere Inc., BioMerieux Inc., Nanologix Inc. And Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. E. COLI TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Testing Methods
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL E. COLI TESTING MARKET ANALYSIS BY TESTING METHODS

  • 5.1. Overview By Testing Methods
  • 5.2. Historical and Forecast Data Analysis By Testing Methods
  • 5.3. Clinical Testing Methods (Enzyme Immunoassays (EIA), Polymerase Chain Reaction, (PCR) Tests, Others) Historic and Forecast Sales By Regions
  • 5.4. Environmental Testing (Enzyme Substrate Methods, Membrane Filtration (MF), Multiple Tube Fermentation (MTF) Historic and Forecast Sales By Regions

6. GLOBAL E. COLI TESTING MARKET ANALYSIS BY END USER

  • 6.1. Overview By End User
  • 6.2. Historical and Forecast Data Analysis By End User
  • 6.3. Clinical Testing Methods (Diagnostic Laboratories, Hospital, Physician Offices) Historic and Forecast Sales By Regions
  • 6.4. Environmental Testing (Bottled Water Suppliers, Home and Drinking Water Suppliers, Waste Water Treatment Organizations, Others (Government Agencies, etc.) Historic and Forecast Sales By Regions

7. GLOBAL E. COLI TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE E. COLI TESTING COMPANIES

  • 8.1. E. Coli Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF E. COLI TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. IDEXX Laboratories Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Meridian Bioscience Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Becton, Dickinson And Company
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Nanologix Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Thermo Fisher Scientific Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. CPI International Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Pro-Lab Diagnostics Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Alere Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. BioMerieux Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Other
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies